Source: RTTNews

Inotek Pharmaceuticals: Inotek Pharmaceuticals Corp. (RCKT) Rose To A New High For The Year

Inotek Pharmaceuticals Corp. (RCKT) climbed during the first 2 hours of trade Monday and advanced further going into the close. Shares finished up by 3.15 at $23.00.

Read full article »
Inotek Pharmaceuticals's Competitors | Inotek Pharmaceuticals's News | Inotek Pharmaceuticals's Financials
Stay up-to-date with the latest news on Inotek Pharmaceuticals
Annual Revenue
$100K-5.0M
Employees
250-500
David P. Southwell's photo - President & CEO of Inotek Pharmaceuticals

President & CEO

David P. Southwell

CEO Approval Rating

70/100

Read more
Stay up-to-date with the latest news on Inotek Pharmaceuticals